Skip to search formSkip to main contentSkip to account menu

sangivamycin

Known as: 4-amino-5-carboxamido-7-(D-ribofuranosyl)-pyrrolo-(2,3-d)pyrimidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Insulin-induced increases in diacylglycerol (DAG) have been suggested to result from stimulation of de novo phosphatidic acid (PA… 
1989
1989
A number of 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine derivatives related to the nucleoside antibiotics toyocamycin and… 
1983
1983
The substrate specificity of the interferon-induced mouse L-cell enzyme, 2',5'-oligoadenylate synthetase, was determined with a… 
1983
1983
A number of the new enzymatically synthesized 2',5'-oligonucleotide trimers, namely, those containing the nucleosides 8… 
1981
1981
The lethal and sublethal effects of sangivamycin (SGM) were studied in sarcoma 180 in vitro in relation to drug concentration and… 
1981
1981
About seventy naturally occurring nucleoside analogs have been isolated to date. As with the numerous other analog types that… 
1974
1974
Summary In vivo studies have established that sangivamycin was phosphorylated and incorporated into the nucleic acids of mouse…